Bruno C. Kohler

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications

Sacituzumab govitecan in colorectal cancer: clinical evidence and future directions.

Sacituzumab govitecan in colorectal cancer: clinical evidence and future directions.

Journal: Future oncology (London, England)
Published: May 27, 2026

Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients.

Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients.

Journal: Cancers
Published: March 21, 2026

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

Journal: ESMO gastrointestinal oncology
Published: February 06, 2026

Functional Precision Medicine Using MicroOrganoSpheres for Treatment Response Prediction in Advanced Colorectal Cancer.

Functional Precision Medicine Using MicroOrganoSpheres for Treatment Response Prediction in Advanced Colorectal Cancer.

Journal: JCO precision oncology
Published: January 15, 2026

Patient and public involvement in the co-design of a multicenter randomized controlled trial on prehabilitation: results from the PREHAB-PEER conceptual phase.

Patient and public involvement in the co-design of a multicenter randomized controlled trial on prehabilitation: results from the PREHAB-PEER conceptual phase.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: December 23, 2025

Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases.

Delaying surgery beyond six weeks after systemic therapy reduces postoperative morbidity without evidence of impaired oncologic outcomes in colorectal liver metastases.

Journal: BMC cancer
Published: October 26, 2025

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

Deep molecular profiling of biliary tract cancer uncovers novel biological mechanisms and therapeutic opportunities.

Journal: ESMO open
Published: September 16, 2025

Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trial.

Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trial.

Journal: BMJ open
Published: June 27, 2025

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Journal: Nature
Published: March 23, 2025

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

Journal: International journal of cancer
Published: March 13, 2025

Association of leukocyte composition ratios from blood methylation with cancer mortality outcomes.

Association of leukocyte composition ratios from blood methylation with cancer mortality outcomes.

Journal: Communications medicine
Published: November 10, 2024

Optimization of multiprofessional care for young colorectal cancer patients: a qualitative Study.

Optimization of multiprofessional care for young colorectal cancer patients: a qualitative Study.

Journal: The oncologist
Published: November 05, 2024
Showing 1-12 of 66

Last Updated: 09/26/2026